Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry - Brenner, E J; Ungaro, R C; Gearry, R B (Gastroenterology, 2020)
et al.